Growth Metrics

Bio-Techne (TECH) Net Cash Flow Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 206.51%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 206.51%
Dec 31, 2025 708.09%
Sep 30, 2025 -152.28%
Jun 30, 2025 23.69%
Mar 31, 2025 -395.14%
Dec 31, 2024 79.40%
Sep 30, 2024 231.96%
Jun 30, 2024 -87.88%
Mar 31, 2024 130.53%
Dec 31, 2023 -177.20%
Sep 30, 2023 -606.10%
Jun 30, 2023 195.43%
Mar 31, 2023 15.36%
Dec 31, 2022 -163.62%
Sep 30, 2022 181.41%
Jun 30, 2022 43.84%
Mar 31, 2022 -337.40%
Dec 31, 2021 232.24%
Sep 30, 2021 -92.89%
Jun 30, 2021 223.10%
Mar 31, 2021 -61.27%
Dec 31, 2020 -240.80%
Sep 30, 2020 1,835.70%
Jun 30, 2020 -281.44%
Mar 31, 2020 547.48%
Dec 31, 2019 180.77%
Sep 30, 2019 104.53%
Jun 30, 2019 -85.66%
Mar 31, 2019 121.17%
Dec 31, 2018 -117.11%
Sep 30, 2018 -40.03%
Jun 30, 2018 35.50%
Mar 31, 2018 -7,487.30%
Dec 31, 2017 635.20%
Sep 30, 2017 -3,468.77%
Jun 30, 2017 4,138.79%
Mar 31, 2017 -86.06%
Dec 31, 2016 -144.39%
Sep 30, 2016 104.83%
Jun 30, 2016 101.29%
Mar 31, 2016 -78.25%
Dec 31, 2015 1,195.05%
Sep 30, 2015 94.71%
Jun 30, 2015 -127.92%
Mar 31, 2015 -33.33%
Dec 31, 2014 -113.72%
Sep 30, 2014 -162.66%
Jun 30, 2014 1,431.14%
Mar 31, 2014 138.62%
Dec 31, 2013 13.06%
Sep 30, 2013 -754.62%
Jun 30, 2013 -43.64%
Mar 31, 2013 -22.07%
Dec 31, 2012 449.75%
Sep 30, 2012 418.95%
Jun 30, 2012 127.18%
Mar 31, 2012 -32.06%
Dec 31, 2011 -90.13%
Sep 30, 2011 -86.07%
Jun 30, 2011 -572.33%
Mar 31, 2011 125.33%
Dec 31, 2010 11.73%
Sep 30, 2010 5.20%